Please login to the form below
8
Revenue 201740
Revenue 2017Enbrel
The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Enbrel was produced by Amgen, Takeda and Pfizer.
US Supreme Court rebuffs Sandoz’s Enbrel biosimilar patent case
The US supreme court has decided not to review a patent case brought forward by Novartis’ generics division Sandoz for its Enbrel biosimilar Erelzi. ... Frustratingly for Sandoz, its Enbrel biosimilar was the first to receive approval from the US Food
Amgen strikes $240m autoimmune deal with Evoq Therapeutics
Otezla fits right into Amgen’s existing psoriasis and anti-inflammatory product range, which includes Enbrel (etanercept) and Amgevita, its biosimilar of AbbVie’s Humira (adalimumab) which is approved and already
Cortellis Drugs to Watch in 2020 report
The drug must leverage its competitive profile as it will face significant competition from entrenched biological agents (and biosimilar versions), including Humira and Enbrel, as well as direct competition from other
Amgen raises forecasts after closing $13.4bn Otezla deal
Otezla slots into Amgen’s existing psoriasis and anti-inflammatory product range, which includes Enbrel (etanercept) and Amgevita, its biosimilar of AbbVie’s Humira (adalimumab) which is approved and already available
UPDATED: BMS completes Celgene merger after FTC okay
Otezla slots nicely into Amgen’s existing psoriasis and anti-inflammatory portfolio, which includes TNF inhibitor Enbrel (etanercept) and Amgevita, its biosimilar of AbbVie’s top-selling TNF blocker Humira (adalimumab).
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
Subscribe to our email news alerts
Featured jobs
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Country Manager, Healthcare Communications Agency, Germany
-
Highly competitive salary
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- bluebird bio reveals plans to launch two gene therapies
- AstraZeneca and MSD’s breast cancer drug Lynparza receives EC approval
- Eli Lilly to make bebtelovimab commercially available to US states from August
- Biogen and Eisai share latest lecanemab results for the treatment of Alzheimer's disease
- The patient voice – the value of patient-reported outcomes in HTA
- AbbVie and Sosei Heptares collaborate in new agreement worth up to $1.2bn
- My body. My choice. Are we all talking about the same thing?
- BeiGene announces positive phase 3 trial results for liver cancer treatment
- Sanofi halts recruitment for trials assessing MS treatment
- Merck and Cerevance to research novel targets in Alzheimer’s disease
- Michael J Fox Foundation awards Koneksa second research grant
- FDA approves Bot Image’s AI software for the detection and diagnosis of prostate cancer
- FDA approves Coherus’ Cimerli as biosimilar interchangeable with Lucentis for all five indications
- Eli Lilly to make bebtelovimab commercially available to US states from August
- AstraZeneca and MSD’s breast cancer drug Lynparza receives EC approval
- Achieving communication excellence by targeting the right channel at the right time
- Oral biologics delivery still elusive
- Biogen and Eisai share latest lecanemab results for the treatment of Alzheimer's disease
PMHub
Hanover Communications
Healthcare is evolving rapidly. To stand out from the crowd requires a potent combination of rich insight, innovative ideas and...
Latest intelligence
- Strategic commitment
- ...
- KOL Ambassador Program & Podcast Creation: A Customer Story
- ...
- Animation: Living With
- The journey from the patient's perspective...
